Elvang Philipp A, Hinna Askell H, Brouwers Joachim, Hens Bart, Augustijns Patrick, Brandl Martin
Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense DK-5230, Denmark.
Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven 3000, Belgium.
J Pharm Sci. 2016 Sep;105(9):2832-2839. doi: 10.1016/j.xphs.2016.03.005. Epub 2016 Apr 19.
Knowledge about colloidal assemblies present in human intestinal fluids (HIFs), such as bile salt micelles and phospholipid vesicles, is regarded of importance for a better understanding of the in vivo dissolution and absorption behavior of poorly soluble drugs (Biopharmaceutics Classification System class II/IV drugs) because of their drug-solubilizing ability. The characterization of these potential drug-solubilizing compartments is a prerequisite for further studies of the mechanistic interplays between drug molecules and colloidal structures within HIFs. The aim of the present study was to apply asymmetrical flow field-flow fractionation (AF4) in combination with multiangle laser light scattering in an attempt to reveal coexistence of colloidal particles in both artificial and aspirated HIFs and to determine their sizes. Asymmetrical flow field-flow fractionation/multiangle laser light scattering analysis of the colloidal phase of intestinal fluids allowed for a detailed insight into the whole spectrum of submicron- to micrometer-sized particles. With respect to the simulated intestinal fluids mimicking fasted and fed state (FaSSIF-V1 and FeSSIF-V1, respectively), FaSSIF contained one distinct size fraction of colloidal assemblies, whereas FeSSIF contained 2 fractions of colloidal species with significantly different sizes. These size fractions likely represent (1) mixed taurocholate-phospholipid-micelles, as indicated by a size range up to 70 nm (in diameter) and a strong UV absorption and (2) small phospholipid vesicles of 90-210 nm diameter. In contrast, within the colloidal phase of the fasted state aspirate of a human volunteer, 4 different size fractions were separated from each other in a consistent and reproducible manner. The 2 fractions containing large particles showed mean sizes of approximately 50 and 200 nm, respectively (intensity-weighted mean diameter, Dz), likely representing mixed cholate/phospholipid micelles and phospholipid vesicles, respectively. The sizes of the smaller 2 fractions being below the size range of multiangle laser light scattering analysis (<20 nm) and their strong UV absorption indicates that they represent either pure cholate micelles or small mixed micelles. Within the colloidal fraction of the fed-state human aspirate, similar colloidal assemblies were detected as in the fasted state human aspirates. The observed differences between SIF and HIF indicate that the simulated intestinal fluids (FaSSIF-V1 and FeSSIF-V1) represent rather simplified models of the real human intestinal environment in terms of coexisting colloidal particles. It is hypothesized that the different supramolecular assemblies detected differ in their lipid composition, which may affect their affinity toward drug compounds and thus the drug-solubilizing capabilities.
由于人类肠液(HIFs)中存在的胶体聚集体,如胆盐微团和磷脂囊泡具有药物增溶能力,因此了解它们对于更好地理解难溶性药物(生物药剂学分类系统II/IV类药物)的体内溶解和吸收行为至关重要。这些潜在的药物增溶区室的表征是进一步研究药物分子与HIFs内胶体结构之间机制相互作用的先决条件。本研究的目的是应用不对称流场-流分级(AF4)结合多角度激光散射,试图揭示人工和抽取的HIFs中胶体颗粒的共存情况并确定其大小。对肠液胶体相进行不对称流场-流分级/多角度激光散射分析,能够详细洞察亚微米至微米级颗粒的整个光谱。对于模拟空腹和进食状态的肠液(分别为FaSSIF-V1和FeSSIF-V1),FaSSIF含有一个独特大小的胶体聚集体部分,而FeSSIF含有两个大小显著不同的胶体物种部分。这些大小部分可能代表:(1)混合牛磺胆酸盐-磷脂-微团,其直径可达70nm且有强烈的紫外吸收;(2)直径为90 - 210nm的小磷脂囊泡。相比之下, 在一名人类志愿者空腹状态抽取物的胶体相中,4个不同大小部分以一致且可重复的方式彼此分离。含有大颗粒的两个部分的平均大小分别约为50nm和200nm(强度加权平均直径,Dz),可能分别代表混合胆酸盐/磷脂微团和磷脂囊泡。较小的两个部分的大小低于多角度激光散射分析的大小范围(<20nm)且有强烈的紫外吸收,这表明它们代表纯胆酸盐微团或小混合微团。在进食状态人类抽取物的胶体部分中,检测到与空腹状态人类抽取物中类似的胶体聚集体。在共存胶体颗粒方面,观察到的模拟肠液(FaSSIF-V1和FeSSIF-V1)与人类肠液之间的差异表明,模拟肠液是真实人类肠道环境的相当简化的模型。据推测,检测到的不同超分子聚集体的脂质组成不同,这可能会影响它们对药物化合物的亲和力,进而影响药物增溶能力。